T.V. Beketova
STANDARD INDUCTION THERAPY OF ANCA-ASSOCIATED SYSTEMIC VASCULITeS: MYTHS AND REALITIES
|
7-13 |
S.N. Ivanov (1), A.Yu. Kochish (1), L.B. Reznik (2), E.V. Sannikova (1)
VIEW OF ORTHOPEDIST-TRAUMATOLOGIST ON THE POSSIBILITY OF USING TERIPARATIDE IN PATIENTS WITH OSTEOPOROTIC BONE FRACTURES
|
14-20 |
T.V. Korotaeva
ADVANCES IN THE TREATMENT OF PSORIATIC ARTHRITIS
|
21-27 |
V.A. Golovacheva, V.A. Parfenov
HOW WE CAN HELP PATIENTS WITH CHRONIC DAILY HEADACHE?
|
28-32 |
G.I. Guliyeva
CLINICAL EFFICACY OF CHONDROGARD IN THERAPY OF OSTEOARTHROSIS
|
33-36 |
M.R. Kuznetsov (1), A.V. Karalkin (2), A.I. Fedin (3), A.O. Virgansky (1), N.V. Kunitsyn (2), E.A. Kholopova (4), S.M. Yumin (1)
POTENTIALS FOR THE PHARMACOLOGICAL PRECONDITIONING IN THE SURGICAL TREATMENT OF HEMODYNAMICALLY SIGNIFICANT CAROTID STENOSIS
|
37-44 |
V.V. Mashin, L.A. Belova, A.N. Proshin, V.V. Abramova
INFLUENCE OF THERAPY WITH CORTEXIN® ON THE RISK OF DEVELOPMENT OF MODS IN ISCHEMIC STROKE
|
45-50 |
L.N.Gorobets, A.G.Lorikyan
STATE OF HYPOTHALAMIC-PITUITARY-ADRENAL SYSTEM IN PATIENTS WITH FIRST PSYCHOTIC EPISODE DURING ANTIPSYCHOTIC THERAPY WITH OLANZAPINE
|
51-55 |
V.V. Ryazhenov (1, 2), S.G. Gorokhov (2, 3), E.R. Volkova (2)
PHARMACOECONOMIC ANALYSIS OF DIFFERENT STRATEGIES OF MONOTHERAPY WITH GENETICALLY ENGINEERED BIOLOGICAL AGENTS IN RUSSIAN PATIENTS WITH RHEUMATOID ARTHRITIS
|
56-60 |
A.A. Godzenko
MODERN POTENTIALS FOR THE TREATMENT OF ANKYLOSING SPONDYLITIS
|
61-65 |
N.M. Bulanov, P.I. Novikov
POTENTIALS FOR THE USE OF LORNOXICAM IN THE TREATMENT OF OSTEOARTHROSIS
|
66-71 |
V.A. Parfenov, A.A. Naumenko, I.S. Preobrazhenskaya
MEDICAL AND DRUG-FREE METHODS OF TREATMENT OF ALZHEIMER'S DISEASE
|
72-79 |
L.N. Gorobets, A.V. Litvinov, L.M. Vasilenko, G.P. Ivanova, V.S. Bulanov, M.A. Tsarenko
GENDER DIFFERENCES IN ANTIPSYCHOTIC TREATMENT OF PATIENTS WITH SCHIZOPHRENIA-RELATED DISORDERS: ENDOCRINOLOGICAL ASPECTS
|
80-86 |
S.G. Anikin, T.A. Korotkova
THE USE OF ALENDRONIC ACID IN THE TREATMENT OF OSTEOPOROSIS
|
87-90 |
N.V. Fedorova, T.K. Kulua
APPLICATION OF LONG ACTING PRAMIPEXOLE AT ADVANCED STAGE OF PARKINSON'S DISEASE. CASE REPORTS
|
91-95 |